Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Prostaglandins|August 1, 1975
Prostaglandins and congeners. IX. The synthesis of 15-deoxy-16-, 17-, or 20-hydroxyprostaglandins and 15-deoxy-15-hydroxymethylprostaglandin E2M B Floyd, R E Schaub, M J WeissBioorganic & Medicinal Chemistry Letters|January 2, 2001
Synthesis and structure-activity relationships of 3-cyano-4-(phenoxyanilino)quinolines as MEK (MAPKK) inhibitorsN Zhang, B Wu, D Powell, et al.Journal of Medicinal Chemistry|August 1, 1980
Prostaglandins and congeners. 22. Synthesis of 11-substituted derivatives of 11-deoxyprostaglandins E1 and E2. Potential bronchodilatorsM B Floyd, R E Schaub, G J Siuta, et al.Bioorganic & Medicinal Chemistry Letters|November 15, 2000
Inhibitors of src tyrosine kinase: the preparation and structure-activity relationship of 4-anilino-3-cyanoquinolines and 4-anilinoquinazolinesY D Wang, K Miller, D H Boschelli, et al.Biochemical Pharmacology|March 23, 1999
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)C M Discafani, M L Carroll, M B Floyd, et al.Journal of Medicinal Chemistry|September 1, 2000
4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitorsA Wissner, D M Berger, D H Boschelli, et al.Pageof 1